NCT04341155View on ClinicalTrials.gov

Dexamethasone for Cerebral Toxoplasmosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions
Toxoplasmosis, Cerebral
Interventions
DRUG

Dexamethasone

Patients in experimental arms will receive i.v. dexamethasone 20 mg (4 ampules = 20mL) for 7 days

DRUG

Placebo

Patients in placebo arms will receive 20 mL normal saline intravenously for 7 days

Trial Locations (1)

40161

RECRUITING

Hasan Sadikin General Hospital, Bandung

All Listed Sponsors
lead

Universitas Padjadjaran

OTHER